Symbols

PLRX

Pliant Therapeutics·NASDAQ

--(--)

4.64 / 10

Netural

Fund flow metrics score 7.2/10, revealing robust fund flow characteristics. Beneficial no significant trends trends are challenged by problematic overall, block, Small, Medium, Large, and Extra-large signals, indicating positive capital movement. Research analyst consensus shows predominantly positive analyst sentiment, demonstrating moderate confidence. Current ratings: Buy(50.0%), Neutral(50.0%) across 2 coverage providers, supported by 2.08 historical weighted rating.

Fund Flow Rating

Analyst RatingBuy

Wall Street Opinions

Buy

Strong Buy

Buy

50%

Hold

Sell

Strong Sell

Date2026-03-13

InstitutionCanaccord Genuity

Times predicted1

Historical Win Rate100.0%

Is money flowing into or out of PLRX?

PLRX holds a Bearish analyst rating, with 50% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.64/10 (Netural).